Literature DB >> 15808258

Inflammatory molecules in the tears of patients with keratoconus.

Isabel Lema1, Juan A Durán.   

Abstract

PURPOSE: To determine levels of a panel of inflammatory molecules and matrix metalloproteinases in the tears of patients with keratoconus.
DESIGN: A prospective, case-control study. PARTICIPANTS: Twenty-eight patients (1 eye from each) diagnosed with keratoconus at the Instituto Galego de Oftalmoloxia, Santiago de Compostela, Spain, during the period from September 2001 to June 2002, and 20 normal control subjects (1 eye each) were studied.
METHODS: Patients with keratoconus were examined in a routine fashion, and keratometric readings were taken to monitor the degree of ectasia. Fifteen microliters of tears was collected by capillary flow from each eye. MAIN OUTCOME MEASURES: The concentrations of cytokines (interleukin-4 [IL-4], IL-6, IL-10, and tumor necrosis factor alpha [TNF-alpha]), cell adhesion molecules (intercellular adhesion molecule 1 and vascular cell adhesion molecule 1), and matrix metalloproteinase 9 (MMP-9) were measured by enzyme-linked immunoadsorbent assay.
RESULTS: Patients with keratoconus initially had significantly higher levels of IL-6 (6.7 [4.8-10.8] pg/ml vs. 2.2 [1.0-4.1] pg/ml in control subjects [P<0.0001]), TNF-alpha (3.8 [2.9-14.4] pg/ml vs. 1.8 [1.5-2.3] pg/ml in control subjects [P<0.0001]), and MMP-9 (66.5 [49.2-139.3]ng/ml vs. 6.1 [3.9-8.3] ng/ml in control subjects. The extent of the increase was found to be associated with the severity of keratoconus.
CONCLUSIONS: Interleukin-6, TNF-alpha, and MMP-9 are overexpressed in the tears of patients with keratoconus, indicating that the pathogenesis of keratoconus may involve chronic inflammatory events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808258     DOI: 10.1016/j.ophtha.2004.11.050

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  79 in total

1.  Association of polymorphisms in the hepatocyte growth factor gene promoter with keratoconus.

Authors:  Kathryn P Burdon; Stuart Macgregor; Yelena Bykhovskaya; Sharhbanou Javadiyan; Xiaohui Li; Kate J Laurie; Dorota Muszynska; Richard Lindsay; Judith Lechner; Talin Haritunians; Anjali K Henders; Durga Dash; David Siscovick; Seema Anand; Anthony Aldave; Douglas J Coster; Loretta Szczotka-Flynn; Richard A Mills; Sudha K Iyengar; Kent D Taylor; Tony Phillips; Grant W Montgomery; Jerome I Rotter; Alex W Hewitt; Shiwani Sharma; Yaron S Rabinowitz; Colin Willoughby; Jamie E Craig
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

2.  Inflammatory cytokine of basal and reflex tears analysed by multicytokine assay.

Authors:  S Sonoda; E Uchino; K Nakao; T Sakamoto
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 3.  Corneal injury: Clinical and molecular aspects.

Authors:  Brayden Barrientez; Sarah E Nicholas; Amy Whelchel; Rabab Sharif; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2019-06-22       Impact factor: 3.467

4.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

Review 5.  Keratoconus: an inflammatory disorder?

Authors:  V Galvis; T Sherwin; A Tello; J Merayo; R Barrera; A Acera
Journal:  Eye (Lond)       Date:  2015-05-01       Impact factor: 3.775

6.  Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.

Authors:  Melek Mutlu; Ozge Sarac; Nurullah Cağıl; Gamze Avcıoğlu
Journal:  Int Ophthalmol       Date:  2019-07-30       Impact factor: 2.031

7.  A case of keratoconus progression associated with the use of topical latanoprost.

Authors:  Shiro Amano; Yoshiyuki Nakai; Akiko Ko; Kenji Inoue; Masato Wakakura
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

8.  Tear film inflammatory mediators in patients with keratoconus.

Authors:  Rana Sorkhabi; Amir Ghorbanihaghjo; Nazli Taheri; Mohammad Hosein Ahoor
Journal:  Int Ophthalmol       Date:  2014-07-26       Impact factor: 2.031

9.  Changes in tear protein profile in keratoconus disease.

Authors:  A Acera; E Vecino; I Rodríguez-Agirretxe; K Aloria; J M Arizmendi; C Morales; J A Durán
Journal:  Eye (Lond)       Date:  2011-06-24       Impact factor: 3.775

Review 10.  Corneal nerves in health and disease.

Authors:  Brittany Simmons Shaheen; May Bakir; Sandeep Jain
Journal:  Surv Ophthalmol       Date:  2014-01-23       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.